+1 (704) 266-3234

Global And United States Viral Inactivation Market Report & Forecast 2022-2028

Published on: May 2022 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 95

Viral Inactivation market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Viral Inactivation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Viral Inactivation market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Segment by Application
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)

1 Study Coverage
1.1 Viral Inactivation Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Introduction
1.2 Global Viral Inactivation Outlook 2017 VS 2022 VS 2028
1.2.1 Global Viral Inactivation Market Size for the Year 2017-2028
1.2.2 Global Viral Inactivation Market Size for the Year 2017-2028
1.3 Viral Inactivation Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Viral Inactivation in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Viral Inactivation Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Viral Inactivation Market Dynamics
1.4.1 Viral Inactivation Industry Trends
1.4.2 Viral Inactivation Market Drivers
1.4.3 Viral Inactivation Market Challenges
1.4.4 Viral Inactivation Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Viral Inactivation by Type
2.1 Viral Inactivation Market Segment by Type
2.1.1 Kits and Reagents
2.1.2 Services
2.1.3 Viral Inactivation Systems and Accessories
2.2 Global Viral Inactivation Market Size by Type (2017, 2022 & 2028)
2.3 Global Viral Inactivation Market Size by Type (2017-2028)
2.4 United States Viral Inactivation Market Size by Type (2017, 2022 & 2028)
2.5 United States Viral Inactivation Market Size by Type (2017-2028)
3 Viral Inactivation by Application
3.1 Viral Inactivation Market Segment by Application
3.1.1 Blood and Blood Products
3.1.2 Cellular and Gene Therapy Products
3.1.3 Stem Cell Products
3.1.4 Tissue and Tissue Products
3.1.5 Vaccines and Therapeutics
3.2 Global Viral Inactivation Market Size by Application (2017, 2022 & 2028)
3.3 Global Viral Inactivation Market Size by Application (2017-2028)
3.4 United States Viral Inactivation Market Size by Application (2017, 2022 & 2028)
3.5 United States Viral Inactivation Market Size by Application (2017-2028)
4 Global Viral Inactivation Competitor Landscape by Company
4.1 Global Viral Inactivation Market Size by Company
4.1.1 Top Global Viral Inactivation Companies Ranked by Revenue (2021)
4.1.2 Global Viral Inactivation Revenue by Player (2017-2022)
4.2 Global Viral Inactivation Concentration Ratio (CR)
4.2.1 Viral Inactivation Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Viral Inactivation in 2021
4.2.3 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Viral Inactivation Headquarters, Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Type
4.3.1 Global Viral Inactivation Headquarters and Area Served
4.3.2 Global Viral Inactivation Companies Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Viral Inactivation Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Viral Inactivation Market Size by Company
4.5.1 Top Viral Inactivation Players in United States, Ranked by Revenue (2021)
4.5.2 United States Viral Inactivation Revenue by Players (2020, 2021 & 2022)
5 Global Viral Inactivation Market Size by Region
5.1 Global Viral Inactivation Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Viral Inactivation Market Size by Region (2017-2028)
5.2.1 Global Viral Inactivation Market Size by Region: 2017-2022
5.2.2 Global Viral Inactivation Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Viral Inactivation Market Size YoY Growth 2017-2028
6.1.2 North America Viral Inactivation Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Viral Inactivation Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Viral Inactivation Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Viral Inactivation Market Size YoY Growth 2017-2028
6.3.2 Europe Viral Inactivation Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Viral Inactivation Market Size YoY Growth 2017-2028
6.4.2 Latin America Viral Inactivation Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Viral Inactivation Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Viral Inactivation Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Danaher
7.1.1 Danaher Company Details
7.1.2 Danaher Business Overview
7.1.3 Danaher Viral Inactivation Introduction
7.1.4 Danaher Revenue in Viral Inactivation Business (2017-2022)
7.1.5 Danaher Recent Development
7.2 Merck
7.2.1 Merck Company Details
7.2.2 Merck Business Overview
7.2.3 Merck Viral Inactivation Introduction
7.2.4 Merck Revenue in Viral Inactivation Business (2017-2022)
7.2.5 Merck Recent Development
7.3 Parker Hannifin
7.3.1 Parker Hannifin Company Details
7.3.2 Parker Hannifin Business Overview
7.3.3 Parker Hannifin Viral Inactivation Introduction
7.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2017-2022)
7.3.5 Parker Hannifin Recent Development
7.4 Sartorius
7.4.1 Sartorius Company Details
7.4.2 Sartorius Business Overview
7.4.3 Sartorius Viral Inactivation Introduction
7.4.4 Sartorius Revenue in Viral Inactivation Business (2017-2022)
7.4.5 Sartorius Recent Development
7.5 SGS
7.5.1 SGS Company Details
7.5.2 SGS Business Overview
7.5.3 SGS Viral Inactivation Introduction
7.5.4 SGS Revenue in Viral Inactivation Business (2017-2022)
7.5.5 SGS Recent Development
7.6 Charles River Laboratories International
7.6.1 Charles River Laboratories International Company Details
7.6.2 Charles River Laboratories International Business Overview
7.6.3 Charles River Laboratories International Viral Inactivation Introduction
7.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2017-2022)
7.6.5 Charles River Laboratories International Recent Development
7.7 Clean Cells
7.7.1 Clean Cells Company Details
7.7.2 Clean Cells Business Overview
7.7.3 Clean Cells Viral Inactivation Introduction
7.7.4 Clean Cells Revenue in Viral Inactivation Business (2017-2022)
7.7.5 Clean Cells Recent Development
7.8 Rad Source Technologies
7.8.1 Rad Source Technologies Company Details
7.8.2 Rad Source Technologies Business Overview
7.8.3 Rad Source Technologies Viral Inactivation Introduction
7.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2017-2022)
7.8.5 Rad Source Technologies Recent Development
7.9 Texcell
7.9.1 Texcell Company Details
7.9.2 Texcell Business Overview
7.9.3 Texcell Viral Inactivation Introduction
7.9.4 Texcell Revenue in Viral Inactivation Business (2017-2022)
7.9.5 Texcell Recent Development
7.10 Viral Inactivated Plasma Systems
7.10.1 Viral Inactivated Plasma Systems Company Details
7.10.2 Viral Inactivated Plasma Systems Business Overview
7.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
7.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2017-2022)
7.10.5 Viral Inactivated Plasma Systems Recent Development
7.11 Wuxi Pharmatech (Cayman)
7.11.1 Wuxi Pharmatech (Cayman) Company Details
7.11.2 Wuxi Pharmatech (Cayman) Business Overview
7.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
7.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2017-2022)
7.11.5 Wuxi Pharmatech (Cayman) Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

List of Tables
Table 1. Viral Inactivation Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Viral Inactivation Market Trends
Table 3. Viral Inactivation Market Drivers
Table 4. Viral Inactivation Market Challenges
Table 5. Viral Inactivation Market Restraints
Table 6. Global Viral Inactivation Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Viral Inactivation Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Viral Inactivation Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Viral Inactivation Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Viral Inactivation Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Viral Inactivation Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Viral Inactivation Revenue Share by Player, 2017-2022
Table 13. Global Viral Inactivation Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Viral Inactivation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2021)
Table 15. Top Players of Viral Inactivation in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Viral Inactivation Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Viral Inactivation Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Viral Inactivation Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Viral Inactivation Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Viral Inactivation Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Viral Inactivation Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Viral Inactivation Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Viral Inactivation Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Viral Inactivation Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Viral Inactivation Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Viral Inactivation Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Viral Inactivation Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Danaher Company Details
Table 31. Danaher Business Overview
Table 32. Danaher Viral Inactivation Product
Table 33. Danaher Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 34. Danaher Recent Development
Table 35. Merck Company Details
Table 36. Merck Business Overview
Table 37. Merck Viral Inactivation Product
Table 38. Merck Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 39. Merck Recent Development
Table 40. Parker Hannifin Company Details
Table 41. Parker Hannifin Business Overview
Table 42. Parker Hannifin Viral Inactivation Product
Table 43. Parker Hannifin Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 44. Parker Hannifin Recent Development
Table 45. Sartorius Company Details
Table 46. Sartorius Business Overview
Table 47. Sartorius Viral Inactivation Product
Table 48. Sartorius Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 49. Sartorius Recent Development
Table 50. SGS Company Details
Table 51. SGS Business Overview
Table 52. SGS Viral Inactivation Product
Table 53. SGS Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 54. SGS Recent Development
Table 55. Charles River Laboratories International Company Details
Table 56. Charles River Laboratories International Business Overview
Table 57. Charles River Laboratories International Viral Inactivation Product
Table 58. Charles River Laboratories International Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 59. Charles River Laboratories International Recent Development
Table 60. Clean Cells Company Details
Table 61. Clean Cells Business Overview
Table 62. Clean Cells Viral Inactivation Product
Table 63. Clean Cells Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 64. Clean Cells Recent Development
Table 65. Rad Source Technologies Company Details
Table 66. Rad Source Technologies Business Overview
Table 67. Rad Source Technologies Viral Inactivation Product
Table 68. Rad Source Technologies Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 69. Rad Source Technologies Recent Development
Table 70. Texcell Company Details
Table 71. Texcell Business Overview
Table 72. Texcell Viral Inactivation Product
Table 73. Texcell Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 74. Texcell Recent Development
Table 75. Viral Inactivated Plasma Systems Company Details
Table 76. Viral Inactivated Plasma Systems Business Overview
Table 77. Viral Inactivated Plasma Systems Viral Inactivation Product
Table 78. Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 79. Viral Inactivated Plasma Systems Recent Development
Table 80. Wuxi Pharmatech (Cayman) Company Details
Table 81. Wuxi Pharmatech (Cayman) Business Overview
Table 82. Wuxi Pharmatech (Cayman) Viral Inactivation Product
Table 83. Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2017-2022) & (US$ Million)
Table 84. Wuxi Pharmatech (Cayman) Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Inactivation Product Picture
Figure 2. Global Viral Inactivation Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Viral Inactivation Market Size 2017-2028 (US$ Million)
Figure 4. United States Viral Inactivation Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Viral Inactivation Market Size 2017-2028 (US$ Million)
Figure 6. United States Viral Inactivation Market Share in Global 2017-2028
Figure 7. Viral Inactivation Report Years Considered
Figure 8. Product Picture of Kits and Reagents
Figure 9. Product Picture of Services
Figure 10. Product Picture of Viral Inactivation Systems and Accessories
Figure 11. Global Viral Inactivation Market Share by Type in 2022 & 2028
Figure 12. Global Viral Inactivation Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Viral Inactivation Market Share by Type (2017-2028)
Figure 14. United States Viral Inactivation Market Share by Type in 2022 & 2028
Figure 15. United States Viral Inactivation Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Viral Inactivation Market Share by Type (2017-2028)
Figure 17. Product Picture of Blood and Blood Products
Figure 18. Product Picture of Cellular and Gene Therapy Products
Figure 19. Product Picture of Stem Cell Products
Figure 20. Product Picture of Tissue and Tissue Products
Figure 21. Product Picture of Vaccines and Therapeutics
Figure 22. Global Viral Inactivation Market Share by Application in 2022 & 2028
Figure 23. Global Viral Inactivation Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Viral Inactivation Market Share by Application (2017-2028)
Figure 25. United States Viral Inactivation Market Share by Application in 2022 & 2028
Figure 26. United States Viral Inactivation Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Viral Inactivation Market Share by Application (2017-2028)
Figure 28. North America Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. UAE Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Danaher Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 57. Merck Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 58. Parker Hannifin Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 59. Sartorius Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 60. SGS Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 61. Charles River Laboratories International Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 62. Clean Cells Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 63. Rad Source Technologies Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 64. Texcell Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 65. Viral Inactivated Plasma Systems Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 66. Wuxi Pharmatech (Cayman) Revenue Growth Rate in Viral Inactivation Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.